Cargando…

Fingolimod for the treatment of neurological diseases—state of play and future perspectives

Sphingolipids are a fascinating class of signaling molecules derived from the membrane lipid sphingomyelin. They show abundant expression in the brain. Complex sphingolipids such as glycosphingolipids (gangliosides and cerebrosides) regulate vesicular transport and lysosomal degradation and their dy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Brunkhorst, Robert, Vutukuri, Rajkumar, Pfeilschifter, Waltraud
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2014
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4162362/ https://www.ncbi.nlm.nih.gov/pubmed/25309325 http://dx.doi.org/10.3389/fncel.2014.00283

Ejemplares similares

Gene Expression Dynamics at the Neurovascular Unit During Early Regeneration After Cerebral Ischemia/Reperfusion Injury in Mice
por: Kestner, Roxane-Isabelle, et al.
Publicado: (2020)

The S1P–S1PR Axis in Neurological Disorders—Insights into Current and Future Therapeutic Perspectives
por: Lucaciu, Alexandra, et al.
Publicado: (2020)

A Sphingosine 1-Phosphate Gradient Is Linked to the Cerebral Recruitment of T Helper and Regulatory T Helper Cells during Acute Ischemic Stroke
por: Lucaciu, Alexandra, et al.
Publicado: (2020)

Beta adrenoceptor blockade ameliorates impaired glucose tolerance and alterations of the cerebral ceramide metabolism in an experimental model of ischemic stroke
por: Luger, Sebastian, et al.
Publicado: (2018)

Blood Levels of Glial Fibrillary Acidic Protein (GFAP) in Patients with Neurological Diseases
por: Mayer, Christoph A., et al.
Publicado: (2013)

Behind the Wall—Compartment-Specific Neovascularisation during Post-Stroke Recovery in Mice
por: Kolbinger, Anja, et al.
Publicado: (2022)

Mechanism of Action and Clinical Potential of Fingolimod for the Treatment of Stroke
por: Li, Wentao, et al.
Publicado: (2016)

Neurological safety of fingolimod: An updated review
por: Yoshii, Fumihito, et al.
Publicado: (2017)

Fingolimod for Irradiation-Induced Neurodegeneration
por: Metzdorf, Judith, et al.
Publicado: (2019)

Modulation of Cardiac Autonomic Function by Fingolimod Initiation and Predictors for Fingolimod Induced Bradycardia in Patients with Multiple Sclerosis
por: Li, Kai, et al.
Publicado: (2017)

Fingolimod as a Treatment in Neurologic Disorders Beyond Multiple Sclerosis
por: Bascuñana, Pablo, et al.
Publicado: (2020)

Preanalytical Biases in the Measurement of Human Blood Sphingolipids
por: Brunkhorst, Robert, et al.
Publicado: (2018)

Coadministration of FTY720 and rt-PA in an experimental model of large hemispheric stroke–no influence on functional outcome and blood–brain barrier disruption
por: Cai, Aijia, et al.
Publicado: (2013)

Sphingosine 1-phosphate levels in cerebrospinal fluid after subarachnoid hemorrhage
por: Männer, Anika, et al.
Publicado: (2020)

The Future of Neurology
por: Biller, José, et al.
Publicado: (2011)

FTY720 Treatment in the Convalescence Period Improves Functional Recovery and Reduces Reactive Astrogliosis in Photothrombotic Stroke
por: Brunkhorst, Robert, et al.
Publicado: (2013)

Determination of Seminal Concentration of Fingolimod and Fingolimod‐Phosphate in Multiple Sclerosis Patients Receiving Chronic Treatment With Fingolimod
por: David, Olivier J., et al.
Publicado: (2017)

A Case of Posterior Reversible Encephalopathy Syndrome Associated with Gilenya(®) (Fingolimod) Treatment for Multiple Sclerosis
por: Lindå, Hans, et al.
Publicado: (2015)

Cannabis Therapeutics and the Future of Neurology
por: Russo, Ethan B.
Publicado: (2018)

Urine-derived stem cells in neurological diseases: current state-of-the-art and future directions
por: Cavaleiro, Carla, et al.
Publicado: (2023)

Advanced genetic therapies for the treatment of Rett syndrome: state of the art and future perspectives
por: Palmieri, Michela, et al.
Publicado: (2023)

How Does Fingolimod (Gilenya(®)) Fit in the Treatment Algorithm for Highly Active Relapsing-Remitting Multiple Sclerosis?
por: Fazekas, Franz, et al.
Publicado: (2013)

Expression of PKM2 in wound keratinocytes is coupled to angiogenesis during skin repair in vivo and in HaCaT keratinocytes in vitro
por: Sych, Khrystyna, et al.
Publicado: (2023)

Neural Coding With Bursts—Current State and Future Perspectives
por: Zeldenrust, Fleur, et al.
Publicado: (2018)

Efficacy and Safety of Fingolimod in Daily Practice: Experience of an Academic MS French Center
por: Roux, Thomas, et al.
Publicado: (2017)

Evaluation of Endovascular Treatment for Acute Basilar Occlusion in a State-Wide Prospective Stroke Registry
por: Gruber, Katharina, et al.
Publicado: (2021)

Fingolimod treatment modulates PPARγ and CD36 gene expression in women with multiple sclerosis
por: Ferret-Sena, Véronique, et al.
Publicado: (2022)

Warfarin Anticoagulation Exacerbates the Risk of Hemorrhagic Transformation after rt-PA Treatment in Experimental Stroke: Therapeutic Potential of PCC
por: Pfeilschifter, Waltraud, et al.
Publicado: (2011)

Fingolimod Inhibits Inflammation but Exacerbates Brain Edema in the Acute Phases of Cerebral Ischemia in Diabetic Mice
por: Li, Wanlu, et al.
Publicado: (2020)

Neuroprotective Effects of Fingolimod Supplement on the Retina and Optic Nerve in the Mouse Model of Experimental Autoimmune Encephalomyelitis
por: Yang, Tao, et al.
Publicado: (2021)

Clostridioides difficile and neurological disorders: New perspectives
por: Biazzo, Manuele, et al.
Publicado: (2022)

Editorial: Investigating the gliomas/white matter interplay and its implications for multidisciplinary treatment: State of art and future perspectives
por: Latini, Francesco, et al.
Publicado: (2022)

Editorial: Cannabinoids as potential treatment for neurological diseases
por: Gómez-Cañas, María, et al.
Publicado: (2022)

Working Memory and Consciousness: The Current State of Play
por: Persuh, Marjan, et al.
Publicado: (2018)

Industrial Perspective on Deep Brain Stimulation: History, Current State, and Future Developments
por: Sarem-Aslani, Ali, et al.
Publicado: (2011)

The Therapeutic Targets of Fingolimod (FTY720) Are Involved in Pathological Processes in the Frontal Cortex of Alzheimer's Disease Patients: A Network Pharmacology Study
por: Yin, Pengqi, et al.
Publicado: (2021)

Age-Related Transcriptional Deregulation of Genes Coding Synaptic Proteins in Alzheimer's Disease Murine Model: Potential Neuroprotective Effect of Fingolimod
por: Jęśko, Henryk, et al.
Publicado: (2021)

Perspectives for computational modeling of cell replacement for neurological disorders
por: Aimone, James B., et al.
Publicado: (2013)

Parkinson’s Disease and the Gut: Future Perspectives for Early Diagnosis
por: Harsanyiova, Jana, et al.
Publicado: (2020)

Treatment with the immunomodulator FTY720 does not promote spontaneous bacterial infections after experimental stroke in mice
por: Pfeilschifter, Waltraud, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_sh6fehnsbt9ja48tqunfln61f1